Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Dermatologic 1

Conditions

Myelodysplastic Syndromes 35Leukemia 33Leukemia, Myeloid, Acute 28Precursor Cell Lymphoblastic Leukemia-Lymphoma 23Myeloproliferative Disorders 21Leukemia, Myeloid, Accelerated Phase 18Congenital Abnormalities 18Lymphoma, Non-Hodgkin 16Lymphoma 16Leukemia, Myelomonocytic, Chronic 16Leukemia, Myeloid, Chronic-Phase 16Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 16Blast Crisis 16Anemia, Refractory, with Excess of Blasts 16Myelodysplastic-Myeloproliferative Diseases 15Multiple Myeloma 13Lymphoma, Large B-Cell, Diffuse 13Primary Myelofibrosis 12Lymphoma, Mantle-Cell 12Leukemia, Lymphocytic, Chronic, B-Cell 12Burkitt Lymphoma 12Neoplasms, Plasma Cell 11Lymphoma, Large-Cell, Immunoblastic 11Lymphoma, Follicular 11Lymphoma, B-Cell, Marginal Zone 10Hodgkin Disease 10Dendritic Cell Sarcoma, Interdigitating 8Polycythemia Vera 7Pdgfra-Associated Chronic Eosinophilic Leukemia 7Lymphohistiocytosis, Hemophagocytic 7

Interventions

liposomal amphotericin B 2Voriconazole 2Polymerase Chain Reaction 2Pentetic Acid 2Moxifloxacin 2Itraconazole 2Fluconazole 2Caspofungin 2fludarabine phosphate 1ethanolamine oleate 1amphotericin B, deoxycholate drug combination 1Whole-Body Irradiation 1Watchful Waiting 1Vancomycin 1Valacyclovir 1Trimethoprim, Sulfamethoxazole Drug Combination 1Trimethoprim 1Therapeutics 1Tazobactam 1Tacrolimus 1Sulfamethoxazole 1Sodium Chloride 1Sirolimus 1Saline Solution, Hypertonic 1Saline Solution 1Ribavirin 1Piperacillin, Tazobactam Drug Combination 1Piperacillin 1Peripheral Blood Stem Cell Transplantation 1Palivizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Infections × Etoposide × Myeloid × Clear all
NCT00589563 2014-09-10

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer

City of Hope Medical Center

Phase 2 Completed
32 enrolled 24 charts
DermatologicLymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Congenital Abnormalities, Burkitt Lymphoma, Graft vs Host Disease, Hodgkin Disease, Immunoblastic Lymphadenopathy, Infections, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Precancerous Conditions, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡